Haier Biomedical Showcases Digital Blood Management Platform at ISBT Congress 2026

Kuala Lumpur, Malaysia – 21 July 2026 – The bustling hall of the ISBT Congress 2026 became a showcase for Haier Biomedical’s ambitious step from a traditional equipment maker to a full‑process solution partner for transfusion medicine.

“We’re not just selling a fridge any more,” said Daniele Pericolini, Automation Solution Specialist, as he walked the audience through the rollout of the R‑Series Automated Blood Management Refrigerator at New Arcispedale Sant’Anna Hospital in Ferrara, Italy. The hospital, previously reliant on paper logs, now enjoys RFID‑tagged blood products that can be retrieved in under a minute. The system boasts ozone sterilisation, automatic inventory control and a ‘zero‑error’ tracking feature that the supplier claims no other vendor provides.

Across the room, Blood Chain Product Manager Zhou Weidong highlighted two more success stories. In Brazil, the HemoRio Blood Bank has adopted the same intelligent refrigeration, while the Asia Pacific Medical Center in the Philippines is already benefitting from a digital workflow that eliminates the need for separate software – everything runs on Haier’s cloud platform, complete with AI‑driven alerts and real‑time temperature monitoring.

The hardware lineup goes beyond refrigerators. The press kit listed an EU‑MDR‑certified Plasma Apheresis System, an Automatic Blood Component Separator and a Plasma Contact Shock Freezer, all engineered to plug into the same IoT backbone. According to the company, the platform links collection, processing, low‑temperature storage, transport and clinical use, delivering an end‑to‑end digital chain that can be monitored from any device.

Geographically, Haier Biomedical says the solution is already active in a string of markets – Germany, Italy, Thailand, the Philippines, Morocco, Brazil, Zambia and Kenya – and it plans to expand further. The firm also touts its proprietary RFID tags, which can be customised for each hospital’s workflow, a claim it positions as a unique market advantage.

While the company’s figures – such as sub‑minute retrieval times and zero‑error rates – are impressive, they come directly from Haier Biomedical’s press release and have not been independently verified. Still, the demonstration at ISBT 2026 makes clear that the company is betting heavily on digital integration as the next frontier for blood‑bank safety and efficiency.